Abstract
Background Late gadolinium enhancement (LGE) MRI provides a significant impact on prognosis in dilated cardiomyopathy (DCM) patients. However, LGE MRI is less suitable for quantifying the degree of fibrosis in diffusely diseased myocardium. T1 mapping technique allows for the quantitative assessment of extracellular volume fraction (ECV), which has been histologically validated against the collagen volume fraction (CVF). Native myocardial T1 also has a potential for the noninvasive detection of myocardial fibrosis. Recent study demonstrated that native myocardial T1 permits the discrimination between normal and diffusely diseased myocardium accurately in DCM patients. However, in-vivo histological validation of native myocardial T1 in DCM patients is still lacking. The aim of this study was to histologically validate native myocardial T1 for the assessment of diffuse myocardial fibrosis in DCM patients.
Highlights
Late gadolinium enhancement (LGE) MRI provides a significant impact on prognosis in dilated cardiomyopathy (DCM) patients
T1 mapping technique allows for the quantitative assessment of extracellular volume fraction (ECV), which has been histologically validated against the collagen volume fraction (CVF)
LGE was observed in 5 of the 20 patients on LGE MRI. Both CVF and native T1 were significantly greater in the patients with LGE than those without LGE (CFV, 27.4 ±15.0 vs 12.7±8.1%, p=0.011; native T1, 1446.8±29.3 ms vs 1381.7±54.3 ms, p=0.021)
Summary
Late gadolinium enhancement (LGE) MRI provides a significant impact on prognosis in dilated cardiomyopathy (DCM) patients. LGE MRI is less suitable for quantifying the degree of fibrosis in diffusely diseased myocardium. T1 mapping technique allows for the quantitative assessment of extracellular volume fraction (ECV), which has been histologically validated against the collagen volume fraction (CVF). Native myocardial T1 has a potential for the noninvasive detection of myocardial fibrosis. Recent study demonstrated that native myocardial T1 permits the discrimination between normal and diffusely diseased myocardium accurately in DCM patients. In-vivo histological validation of native myocardial T1 in DCM patients is still lacking. The aim of this study was to histologically validate native myocardial T1 for the assessment of diffuse myocardial fibrosis in DCM patients
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
